To address medicine shortages and supply chain disruptions, this project introduces an agile manufacturing platform for pharmacies and hospital pharmacies. Using 3D-inspired robotic dosing, AI-driven analytics, RFID tracking, and workflow automation, the system ensures real-time, scalable, and regulatory-compliant production of essential medicines. By decentralising pharmaceutical manufacturing, it enables rapid responses to crises, reduces bottlenecks and waste, and enhances EU healthcare resilience.
- Beneficiaries
Coordinators: Curifylabs OY
Participants: AtrimusRx AB - Fysioline Oy - Pharmacie Delpech - Sihtasutus tartu ulikooli kliinikum - Universitaetsmedizin der Johannes Gutenberg-universitaet Mainz - Vaasan Hietalahden apteekki
- Project Locations
Finland - Sweden - France - Estonia - Germany
- EU contribution
€ 3.36 million
- Funding sources
Explore EU innovative projects awarded the STEP Seal. View projects’ details, funding status, and connect with promoters via the interactive dashboard.
Other STEP stories on biotech
- Highlighted
In Warsaw, STEP is supporting a pioneering gene therapy for Parkinson’s disease, helping strengthen Europe’s leadership in biotechnology and advanced medical research.
PharmSD 3.0 will develop an integrated, continuous-pharmaceutical spray drying process to enhance efficiency, scalability, and cost-effectiveness.
SmartNEBI will develop a sustainable, enzyme-based synthesis of heart-medicine nebivolol to enhance sustainability, scalability, and EU pharmaceutical sovereignty.